Abound Wealth Management
TMDX icon

Abound Wealth Management’s Transmedics TMDX Stock Holding History

Abound Wealth Management’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$84 Hold
1
– – ﹤0.01% 1382
2026
Q2 		$67 Hold
1
– – ﹤0.01% 1335
2026
Q1 		$100 Sell
1
-1
-50% -$130 ﹤0.01% 1417
2025
Q4 		$244 Hold
2
– – ﹤0.01% 1114
2025
Q3 		$225 Hold
2
– – ﹤0.01% 1083
2025
Q2 		$269 Hold
2
– – ﹤0.01% 951
2025
Q1 		$135 Hold
2
– – ﹤0.01% 1149
2024
Q4 		$125 Buy
+2
New +$186 ﹤0.01% 1192

Other funds holding TMDX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Emerald Advisers
Emerald Advisers Leola, Pennsylvania $3.64B AUM 71.19% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
Wasatch Advisors
Wasatch Advisors Salt Lake City, Utah $13.5B AUM 16.58% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Emerald Mutual Fund Advisers Trust
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.45B AUM 70.46% 1-Year Est. Return
Zevenbergen Capital Investments
Zevenbergen Capital Investments Edmonds, Washington $4.37B AUM 52.9% 1-Year Est. Return

Abound Wealth Management's TMDX Position: Q3 2026 in Review

Abound Wealth Management held its Transmedics (TMDX) position steady in Q3 2026 at 1 share worth $84. The position accounts for ﹤0.01% of the portfolio, ranked #1382.

Abound Wealth Management first reported a position in TMDX in Q4 2024 and has held it in 8 quarters since. The position peaked at $269 in Q2 2025. 217 funds tracked by Wall St. Rank hold TMDX as of Q3 2026.

  • Abound Wealth Management held 1 share of Transmedics worth $84 as of Q3 2026.
  • Abound Wealth Management left its Transmedics share count unchanged in Q3 2026.
  • Transmedics made up ﹤0.01% of Abound Wealth Management's portfolio in Q3 2026, its #1382 holding.
  • Abound Wealth Management first reported a position in Transmedics in Q4 2024 and has held it in 8 quarters since.
  • Abound Wealth Management's Transmedics position peaked at $269 in Q2 2025.
  • 217 funds tracked by Wall St. Rank held Transmedics as of Q3 2026.

Based on Abound Wealth Management's 13F filing for Q3 2026, filed 26 Oct 2026.